Abstract:
The invention concerns a novel solid pharmaceutical composition, with controlled release, obtained by hot-process thermoforming of a mixture based on polymers belonging to the polymethacrylate family, and Ivabradine or one of its pharmaceutically acceptable salts.
Abstract:
Comprimido matricial para la liberación prolongada de trimetazidina, o de una de sus sales farmacéuticamente aceptables, caracterizado porque la liberación prolongada se controla mediante un polímero derivado de celulosa presente en la matriz seleccionado entre hidroxipropilcelulosa, hidroxietilcelulosa, hidroximetilcelulosa, metilcelulosa e hidroxipropilmetilcelulosa.
Abstract:
Controlled release solid pharmaceutical compositions containing an active material and one or more polymethacrylates. The compositions are prepared by thermoforming a mixture of the active material and the polymethacrylate(s), the release properties being determined by the nature of the polymethacrylate(s), their relative amounts, and the technique used to make the compositions. Preferably the polymethacrylate(s) are Eudragit (RTM) RL and/or RS, optionally with Eudragit E. The ingredients are mixed and then thermoformed at 60 - 150 degrees C, preferably 80 - 130 degrees C by an extrusion or injection process. The use of a co-extrusion or co-injection procedure, in which the inner and outer layers have different compositions is particularly preferred. Additional components that may be incorporated include antioxidants, flavors, colors, preservatives, sweeteners, and anti-adherents.
Abstract:
The invention relates to a solid orodispersible pharmaceutical composition of ivabradine, characterised in that it comprises ivabradine or a pharmaceutically acceptable salt thereof and granules consisting of co-dried lactose and starch.
Abstract:
ORODISPERSIBLE PHARMACEUTICAL COMPOSITION FOR OROMUCOSAL OR SUBLINGUAL ADMINISTRATION OF AGOMELATINE The invention relates to a coated solid orodispersible pharmaceutical composition for the administration of agomelatine by the oral, oromucosal or sublingual route.
Abstract:
L~invention a pour objet une composition pharmaceutique solide orodispersible d~agomélatine caractérisée en ce qu~elle contient de l~agomélatine et des granules consistant en lactose et amidon coséchés.